skip to main content
Ngôn ngữ:
Giới hạn tìm kiếm: Giới hạn tìm kiếm: Dạng tài nguyên Hiển thị kết quả với: Hiển thị kết quả với: Chỉ mục

Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries

Falla, Abby M ; Veldhuijzen, Irene K ; Ahmad, Amena A ; Levi, Miriam ; Hendrik Richardus, Jan

The European Journal of Public Health, 2017, Vol. 27(2), pp.302-306 [Tạp chí có phản biện]

ISSN: 1101-1262 ; E-ISSN: 1464-360X ; DOI: 10.1093/eurpub/ckw100

Truy cập trực tuyến

Trích dẫn Trích dẫn bởi
  • Nhan đề:
    Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries
  • Tác giả: Falla, Abby M ; Veldhuijzen, Irene K ; Ahmad, Amena A ; Levi, Miriam ; Hendrik Richardus, Jan
  • Là 1 phần của: The European Journal of Public Health, 2017, Vol. 27(2), pp.302-306
  • Mô tả: Background: To investigate access to treatment for chronic hepatitis B/C among six vulnerable patient/population groups at-risk of infection: undocumented migrants, asylum seekers, people without health insurance, people with state insurance, people who inject drugs (PWID) and people abusing alcohol. Methods: An online survey among experts in gastroenterology, hepatology and infectious diseases in 2012 in six EU countries: Germany, Hungary, Italy, the Netherlands, Spain and the UK. A four-point ordinal scale measured access to treatment (no, some, significant or complete restriction). Results: From 235 recipients, 64 responses were received (27%). Differences in access between and within countries were reported for all groups except people with state insurance. Most professionals, other than in Spain and Hungary, reported no or few restrictions for PWID. Significant/complete treatment restriction was reported for all groups by the majority in Hungary and Spain, while Italian respondents reported no/few restrictions. Significant/complete restriction was reported for undocumented migrants and people without health insurance in the UK and Spain. Opinion about undocumented migrants in Germany and the Netherlands was divergent. Conclusions: Although effective chronic hepatitis B/C treatment exists, limited access among vulnerable patient populations was seen in all study countries. Discordance of opinion about restrictions within countries is seen, especially for groups for whom the health care system determines treatment access, such as undocumented migrants, asylum seekers and people without health insurance. This suggests low awareness, or lack, of entitlement guidance among clinicians. Expanding treatment access among risk groups will contribute to reducing chronic viral hepatitis-associated avoidable morbidity and mortality.
  • Số nhận dạng: ISSN: 1101-1262 ; E-ISSN: 1464-360X ; DOI: 10.1093/eurpub/ckw100

Đang tìm Cơ sở dữ liệu bên ngoài...